Relay Therapeutics, Inc.
The momentum for this stock is not very good. Relay Therapeutics, Inc. is not a good value stock. Relay Therapeutics, Inc. is not very popular among insiders. Relay Therapeutics, Inc. is a mediocre stock to choose.
Log in to see more information.
News
Relay Therapeutics (NASDAQ:RLAY) PT Raised to $24.00 at Bank of America
Ticker Report Relay Therapeutics (NASDAQ:RLAY - Get Free Report) had its target price lifted by research analysts at Bank of America from $20.00 to $24.00 in a report issued on Tuesday, Benzinga reports. The firm...\n more…
Jefferies Financial Group Upgrades Relay Therapeutics (NASDAQ:RLAY) to "Buy"
Ticker Report Relay Therapeutics (NASDAQ:RLAY - Get Free Report) was upgraded by equities researchers at Jefferies Financial Group from a "hold" rating to a "buy" rating in a research note issued on Tuesday...\n more…